Clover Health Investments Corp is a healthcare technology company. It focuses on empowering Medicare physicians to proactively manage chronic diseases through its proprietary software platform, Clover Assistant. This cloud-based solution provides personalized insights to physicians, enabling early detection and management of chronic conditions. It operates in one segment: Insurance, through which it offers PPO and HMO plans to Medicare Advantage members in several states.
2019
570
LTM Revenue $1.6B
LTM EBITDA $64.1M
$1.3B
Benchmark forward-looking revenue and EBITDA valuation multiples across generative AI, climate tech, semiconductors, online marketplaces, vertical SaaS and 220 more verticals.
Clover Health has a last 12-month revenue (LTM) of $1.6B and a last 12-month EBITDA of $64.1M.
In the most recent fiscal year, Clover Health achieved revenue of $1.4B and an EBITDA of -$44.9M.
Clover Health expects next 12-month revenue of XXX   and NTM EBITDA of XXX
See Clover Health valuation multiples based on analyst estimatesLTM | NTM | Last FY | FY 2025 | FY 2026 | FY 2027 | |
---|---|---|---|---|---|---|
Revenue | $1.6B | XXX | $1.4B | XXX | XXX | XXX |
Gross Profit | $1.6B | XXX | $365M | XXX | XXX | XXX |
Gross Margin | 100% | XXX | 27% | XXX | XXX | XXX |
EBITDA | $64.1M | XXX | -$44.9M | XXX | XXX | XXX |
EBITDA Margin | 4% | XXX | -3% | XXX | XXX | XXX |
EBIT | -$37.1M | XXX | -$45.5M | XXX | XXX | XXX |
EBIT Margin | -2% | XXX | -3% | XXX | XXX | XXX |
Net Profit | -$52.5M | XXX | -$43.0M | XXX | XXX | XXX |
Net Margin | -3% | XXX | -3% | XXX | XXX | XXX |
Net Debt | XXX | XXX | n/a | XXX | XXX | XXX |
Financial data powered by Morningstar, Inc.
As of May 30, 2025, Clover Health's stock price is $3.
Clover Health has current market cap of $1.6B, and EV of $1.3B.
See Clover Health trading valuation dataEV | Market Cap | Price 1D | Price 1M | Price 3M | Price 12M | EPS |
---|---|---|---|---|---|---|
$1.3B | $1.6B | XXX | XXX | XXX | XXX | $-0.08 |
Sign up to access valuation multiples like growth-adjusted P/E, next 12-month EV/Revenue, EBITDA multiples by industry and many more
Start Free TrialAs of May 30, 2025, Clover Health has market cap of $1.6B and EV of $1.3B.
Clover Health's trades at 0.9x EV/Revenue multiple, and -28.2x EV/EBITDA.
Equity research analysts estimate Clover Health's 2025E EV/Revenue multiple at XXX and 2025E EV/EBITDA multiple at XXX
Clover Health has a P/E ratio of -30.4x.
See valuation multiples for Clover Health and 12K+ public compsLTM | NTM | Last FY | FY 2025 | FY 2026 | FY 2027 | |
---|---|---|---|---|---|---|
Market cap (current) | $1.6B | XXX | $1.6B | XXX | XXX | XXX |
EV (current) | $1.3B | XXX | $1.3B | XXX | XXX | XXX |
EV/Revenue | 0.8x | XXX | 0.9x | XXX | XXX | XXX |
EV/EBITDA | 19.8x | XXX | -28.2x | XXX | XXX | XXX |
EV/EBIT | -34.2x | XXX | -27.9x | XXX | XXX | XXX |
EV/Gross Profit | 0.8x | XXX | n/a | XXX | XXX | XXX |
P/E | -30.4x | XXX | -37.2x | XXX | XXX | XXX |
EV/FCF | 36.8x | XXX | 38.1x | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Access all public comps and forward-looking valuation multiples like EV/Revenue in 2025, based on equity research analyst estimates.
Start Free TrialClover Health's last 12 month revenue growth is 29%
Clover Health's revenue per employee in the last FY averaged $2.4M, while opex per employee averaged $0.7M for the same period.
Clover Health's rule of 40 is 19% (metric relevant for SaaS companies only, counted as combined revenue growth rate and EBITDA margin).
Clover Health's rule of X is 77% (created by Bessemer, rule of X is another metric relevant for SaaS companies only, ~1.5x stronger vs. the traditional Rule of 40, counted as revenue growth rate multiplied by 2.5 plus EBITDA margin).
See operational valuation multiples for Clover Health and other 12K+ public compsLTM | NTM | Last FY | FY 2025 | FY 2026 | FY 2027 | |
---|---|---|---|---|---|---|
Revenue Growth | 29% | XXX | 29% | XXX | XXX | XXX |
EBITDA Margin | 4% | XXX | -3% | XXX | XXX | XXX |
EBITDA Growth | 8% | XXX | n/a | XXX | XXX | XXX |
Rule of 40 | 19% | XXX | 26% | XXX | XXX | XXX |
Bessemer Rule of X | XXX | XXX | 77% | XXX | XXX | XXX |
Revenue per Employee | XXX | XXX | $2.4M | XXX | XXX | XXX |
Opex per Employee | XXX | XXX | $0.7M | XXX | XXX | XXX |
S&M Expenses to Revenue | XXX | XXX | n/a | XXX | XXX | XXX |
G&A Expenses to Revenue | XXX | XXX | n/a | XXX | XXX | XXX |
R&D Expenses to Revenue | XXX | XXX | n/a | XXX | XXX | XXX |
Opex to Revenue | XXX | XXX | 30% | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Benchmark public comps and private revenue and EBITDA valuation multiples across GRC software, cloud infrastructure, DevOps, online marketplaces and so much more!
EV/Revenue | EV/EBITDA | |||||
---|---|---|---|---|---|---|
2025E | 2026E | 2027E | 2025E | 2026E | 2027E | |
Genesis Fertility Center | XXX | XXX | XXX | XXX | XXX | XXX |
Dc Healthcare Holdings | XXX | XXX | XXX | XXX | XXX | XXX |
Health Italia | XXX | XXX | XXX | XXX | XXX | XXX |
Alignment Healthcare | XXX | XXX | XXX | XXX | XXX | XXX |
Molina Healthcare | XXX | XXX | XXX | XXX | XXX | XXX |
XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc.
Clover Health acquired XXX companies to date.
Last acquisition by Clover Health was XXXXXXXX, XXXXX XXXXX XXXXXX . Clover Health acquired XXXXXXXX for XXX (EV/Revenue multiple of XXX ).
See M&A valuation multiplesAcquired Company | EV | EV/Revenue | EV/EBITDA |
---|---|---|---|
XXXXXXXXX | XXX | XXX | XXX |
XXXXXXXXX | XXX | XXX | XXX |
XXXXXXXXX | XXX | XXX | XXX |
XXXXXXXXX | XXX | XXX | XXX |
XXXXXXXXX | XXX | XXX | XXX |
Sign up to see revenue and EBITDA valuation multiples for 60K+ M&A deals.
Start Free TrialWhen was Clover Health founded? | Clover Health was founded in 2019. |
Where is Clover Health headquartered? | Clover Health is headquartered in United States of America. |
How many employees does Clover Health have? | As of today, Clover Health has 570 employees. |
Who is the CEO of Clover Health? | Clover Health's CEO is Mr. Andrew Toy. |
Is Clover Health publicy listed? | Yes, Clover Health is a public company listed on NAS. |
What is the stock symbol of Clover Health? | Clover Health trades under CLOV ticker. |
When did Clover Health go public? | Clover Health went public in 2021. |
Who are competitors of Clover Health? | Similar companies to Clover Health include e.g. Genesis Fertility Center, Dc Healthcare Holdings, Health Italia, Alignment Healthcare. |
What is the current market cap of Clover Health? | Clover Health's current market cap is $1.6B |
What is the current revenue of Clover Health? | Clover Health's last 12 months revenue is $1.6B. |
What is the current revenue growth of Clover Health? | Clover Health revenue growth (NTM/LTM) is 29%. |
What is the current EV/Revenue multiple of Clover Health? | Current revenue multiple of Clover Health is 0.8x. |
Is Clover Health profitable? | Yes, Clover Health is EBITDA-positive (as of the last 12 months). |
What is the current EBITDA of Clover Health? | Clover Health's last 12 months EBITDA is $64.1M. |
What is Clover Health's EBITDA margin? | Clover Health's last 12 months EBITDA margin is 4%. |
What is the current EV/EBITDA multiple of Clover Health? | Current EBITDA multiple of Clover Health is 19.8x. |
What is the current FCF of Clover Health? | Clover Health's last 12 months FCF is $34.4M. |
What is Clover Health's FCF margin? | Clover Health's last 12 months FCF margin is 2%. |
What is the current EV/FCF multiple of Clover Health? | Current FCF multiple of Clover Health is 36.8x. |
Get access to always up-to-date, precisely categorized 70K+ public and private valuation multiples, across tech and beyond.